Not a very good description, Hope, but there you are.
although, reading winners posts, he's already at "excited":D
Printable View
Sounds like PEB is already in talks with potential partners.
From what I understand, the pharmaceutical company carrying out the clinical trials will have to have their procedure including that of PEB's go through an ethics committee..
My question is does this test itself have to go through a clinical trial test?
Yes, one would expect so, Pacific Edge will need to achieve regulatory approvals also to go fully commercial.
In the context of working with a partner, it may be that they sequence their respective trials and work toward commercialisation in parallel, over say at a guess, a 24 month duration.
Though, in the example I posted yesterday, Oryzon were provided with $21 million from Roche up front when the partnership was formed, plus an agreement for potential development, commercial and sales milestone payments that could exceed $500 million, together with tiered royalties on sales which range up to mid-double digits.
http://www.roche.com/research_and_de...2014-04-07.htm
All these sort of developments will have different values, however it does seem likely that a similar type of agreement may be reached between Pacific Edge and any prospective partner.
The commercial windfall comment this morning from David Darling was interesting in this context.
Traders be trading. Large resistance at 96, I'm gonna look for another dip. Will likely need more good news to keep up the rise for now.
If it cruses along at this level for a while till the next development thats fine --no need for greed--a bit of ''steady as she goes'' is not a bad thing.
Shall we have some fun and guess where the SP will end on today? and what it will be on open Monday?
Time to see some action - nearing close of market.
To be honest, I'm looking for some opportunistic buying - the nervous nellies who will fund my next AMG.